AAVIN
AAVIN is a Midwestern based private equity firm. We invest in high-growth opportunities, management buyouts and certain recapitalization transactions. We partner with strong management teams seeking to build businesses through internal growth or acquisitions. We invest primarily in late-stage and expansion-stage financings. Our focus is on smaller investment opportunities – companies seeking less than $10 million, with most requesting less than $5 million. Our activities are concentrated in the Middle America region of the United States. AAVIN has extensive private equity investment experience with a long history of serving as lead investors in venture capital financings. Our five-member investment team has over 120 years of cumulative investment and business development experience and has made investments in over 125 companies. AAVIN's investment team combines financial and operational expertise and we have broad expertise in a variety of industries. We provide significant value over the life of our investments through active involvement. We provide assistance to our management teams in many areas including strategic planning, finance, marketing, recruiting, analyzing and closing acquisitions or divestitures, developing treasury strategies and assessing financial markets.
Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its therapeutic ultrasound platform. Celleration’s core product, the MIST Ultrasound Healing Therapy® System delivers low frequency ultrasound through a saline mist. Unlike conventional wound treatments that are limited to treating the surface, MIST Therapy delivers ultrasound energy into and below the wound bed to stimulate cells to positively impact all critical aspects of the wound healing process. Celleration received 510K clearance from the FDA in 2005 with the full claim of “promote wound healing”. Shortly thereafter, the company introduced the MIST Therapy System to the US market and has since built an impressive body of clinical evidence demonstrating significant clinical and economic benefits in hundreds of facilities across the United States. Currently, over over 1 million MIST® Therapy treatments have been performed in the United States and U.K. benefiting more than 65,000 patients.
Coolibar designs, manufactures, and markets sun protection products for men, women, and children. The company’s portfolio of products includes sun protective clothes, SPF clothing, sun hats, sun protection swimwear, sunglasses, umbrellas, and sunscreens. Coolibar was founded in 2001 by [John Barrow](https://www.crunchbase.com/person/john-barrow) and is based in Minneapolis, Minnesota.
WindLogics (formerly SSESCO) provides advanced wind analysis and forecasting services for wind energy developers, investors, bankers, operators and utilities by scientifically evaluating potential wind energy sites and forecasting and optimizing ongoing operations in real time. WindLogics is able to calculate 3D wind fields based on exclusive historic weather data archives and proven meteorological models adapted to wind power applications.
FENA Design is a tech-based design company. It designs and manufactures standing power mobility devices. The company offers Vertran, a power wheelchair that give the wheelchair bound the ability to stand and navigate through their home, office, or outdoors. The company was founded in 1992 and is headquartered in Plymouth, Minnesota.
Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its therapeutic ultrasound platform. Celleration’s core product, the MIST Ultrasound Healing Therapy® System delivers low frequency ultrasound through a saline mist. Unlike conventional wound treatments that are limited to treating the surface, MIST Therapy delivers ultrasound energy into and below the wound bed to stimulate cells to positively impact all critical aspects of the wound healing process. Celleration received 510K clearance from the FDA in 2005 with the full claim of “promote wound healing”. Shortly thereafter, the company introduced the MIST Therapy System to the US market and has since built an impressive body of clinical evidence demonstrating significant clinical and economic benefits in hundreds of facilities across the United States. Currently, over over 1 million MIST® Therapy treatments have been performed in the United States and U.K. benefiting more than 65,000 patients.
WindLogics (formerly SSESCO) provides advanced wind analysis and forecasting services for wind energy developers, investors, bankers, operators and utilities by scientifically evaluating potential wind energy sites and forecasting and optimizing ongoing operations in real time. WindLogics is able to calculate 3D wind fields based on exclusive historic weather data archives and proven meteorological models adapted to wind power applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.